Trump closes first round of drug pricing deals
US President Trump has hailed a deal with Regeneron to reduce prices on certain medications and invest in new treatments. As part of the agreement, Regeneron will lower prices for Medicaid patients and provide cholesterol medicine Praluent at $225.
Advertisement: Article Inline